Brian Pomper, The Hill; The real US patent 'crisis'
"The true crisis in our patent system is the dire state of Section 101
jurisprudence, the area of law determining what is and what is not
eligible for patent protection. For nearly 150 years, Section 101 of the
U.S. Patent Act was interpreted to allow inventions to be patented
across broad categories and subject matters. These patents incentivized
American R&D and innovation and led to countless technological and
medical breakthroughs.
Starting in 2010, however, the Supreme Court issued a series of decisions that have upended longstanding settled law and narrowed the scope of patent-eligible subject matter...
Restoring clear patent rights will be essential to maintaining a strong and healthy U.S. innovation ecosystem...
So yes, patent quality is important, and we must provide the USPTO with
the resources it needs to carefully weigh patent applications and make
consistent, defensible and predictable decisions. But the real patent
crisis we face is the inability of innovators to get patents for their
new inventions under Section 101."
Issues and developments related to IP, AI, and OM, examined in the IP and tech ethics graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology", coming in Summer 2025, includes major chapters on IP, AI, OM, and other emerging technologies (IoT, drones, robots, autonomous vehicles, VR/AR). Kip Currier, PhD, JD
Showing posts with label tech and medical breakthroughs. Show all posts
Showing posts with label tech and medical breakthroughs. Show all posts
Wednesday, December 11, 2019
Subscribe to:
Posts (Atom)